Saad Akram
CEO
MVision AI
MVision AI provides an AI‑driven platform for radiotherapy planning that automates guideline‑based segmentation of tumors and organs at risk. Its GBS™ suite combines Contour+, Guide, and Verify modules to standardize contours, cut manual contouring time by up to 95%, and improve consistency by about 20%, enabling faster, reproducible treatment plans for radiation oncology departments.
- Artificial Intelligence
- Healthcare Technology
- Software Only
Updated 2 months ago
Funding
Raised to date
€7.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Est. $7.7Macross 2 rounds
€5.4M · Seed
Announced Mar 2023 · from article date
Disclosed cumulative: $7.5M
2/2
RoundDateAmountValuationInvestors
Founders
Product
Problem
Radiotherapy treatment planning relies heavily on manual contouring of tumors and organs at risk, a process that is time‑consuming, prone to inter‑operator variability, and can delay therapy initiation.
Solution
MVision AI offers an AI‑driven platform that automates guideline‑based segmentation through its GBS™ suite, which integrates Contour+, Guide, and Verify modules. The system standardizes contours according to clinical protocols, reducing manual effort by up to 95% and improving consistency by an average of 20%. Processed scans are uploaded, segmented, and validated within a unified workflow, enabling clinicians to generate treatment plans faster while maintaining high quality. The platform’s AI models are trained on large datasets of radiotherapy images, ensuring reliable performance across diverse cancer sites. By delivering rapid, reproducible segmentations, MVision AI helps clinics accelerate patient throughput and enhance treatment accuracy.
Target Audience
Primary customers are radiation oncology departments, medical physicists, and dosimetrists in hospitals and cancer centers that require efficient, standardized radiotherapy planning.
Features
- Guideline‑based segmentation combining Contour+, Guide, and Verify in a single workflow
- AI models that automatically delineate tumors and organs at risk with high precision
- Integrated quality‑check module that verifies adherence to clinical protocols
- Up to 95% reduction in manual contouring time, accelerating plan preparation
- Consistency improvement of approximately 20% across operators and sites
- Cloud‑enabled processing of over 100 k scans annually, ensuring scalability